David Crawford
Healthcare Compliance Director & HIPAA Privacy OfficerHenry ScheinDavid Crawford has over 20 years of experience in healthcare compliance, payment integrity, privacy, audit, and investigations. At Henry Schein, he leads the global conflict of interest program, government contracting compliance, HIPAA, and healthcare compliance for businesses involved in Medicare, Medicaid, and commercial claims services.
His prior roles include senior leadership at Affinity Health Plan, where he oversaw compliance and the Special Investigations Unit (SIU), fraud prevention at NewYork-Presbyterian Hospital, and serving as a Senior Special Agent with the Ohio Attorney General’s Medicaid Fraud Control Unit (MFCU).
David holds an MBA from Hofstra University, an Executive Leadership Certificate from Cornell University, and a BA in Criminal Justice from Baldwin Wallace University, along with multiple industry certifications.
AU03: Payer, Provider, and Advisor Panel on Fraud, Waste, Abuse, and Payment Integrity
In today’s evolving healthcare landscape, collaboration is key to combating fraud, waste, and abuse in the DMEPOS sector. This dynamic panel brings to…In today’s evolving healthcare landscape, collaboration is key to combating fraud, waste, and abuse in the DMEPOS sector. This dynamic panel brings together payers, providers, and consultants to shift the narrative from “us vs. them” to a unified app…In today’s evolving healthcare landscape, collaboration is key to combating fraud, waste, and abuse in the DMEPOS sector. This dynamic panel brings together payers, providers, and consultants to shift the narrative from “us vs. them” to a unified approach to payment integrity. Attendees will gain a comprehensive understanding of claims processing workflows, audit strategies, common fraud, waste, and abuse patterns, and recent trends. Panelists will share real-world insights and actionable strategies to foster transparency, improve compliance, and build trust across the healthcare continuum. Attendees will: 1. Understand the end-to-end claims processing lifecycle and how it impacts payment integrity as a provider and payer. 2. Be able to describe common fraud, waste, and abuse schemes and learn about current trends in the DMEPOS space and how they are identified. 3. Learn collaborative strategies that providers and payers can use to prevent fraud, waste, and abuse before it occurs. 4. Understand the role of advisors and compliance officers in bridging gaps between stakeholders. 5. Leave with action steps to enhance fraud, waste, and abuse prevention/detection and payment integrity efforts.Show MoreClick the title to see all details
LEG01: One Big Beautiful Bill: Impact on Medicaid Programs and DME Suppliers
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill (“Bill”). The 870-page bill covers almost ever component of the economy an…On July 4, 2025, President Trump signed into law the One Big Beautiful Bill (“Bill”). The 870-page bill covers almost ever component of the economy and extends many of the taxpayer-friendly provisions of the Tax Cuts and Jobs Act , passed in Presiden…On July 4, 2025, President Trump signed into law the One Big Beautiful Bill (“Bill”). The 870-page bill covers almost ever component of the economy and extends many of the taxpayer-friendly provisions of the Tax Cuts and Jobs Act , passed in President Trump’s first term. The Bill significantly alters Medicaid by, among other provisions, reducing federal Medicaid spending by an estimated $911 billion over 10 years, largely through coverage losses. A result is a projected additional 11.8 million Americans becoming uninsured by 2034. The Bill includes provisions that will likely make it more difficult to enroll and maintain Medicaid coverage. Additionally, the Bill makes it more difficult for states to raise Medicaid funds through provider taxes. The anticipated cuts in Medicaid funding will (i) directly affect DME suppliers that serve Medicaid patients and (ii) indirectly affect all DME suppliers. This program will (i) summarize the elements of the Bill and (ii) then pivot to discussing the provisions of the Bill that impact state Medicaid programs. The program will focus on how the Bill will (i) directly impact DME suppliers that serve Medicaid patients and (ii) indirectly impact all DME suppliers. Lastly, the program will discuss steps that DME suppliers can take to operate within the confines of the Bill. Learning Objectives: Understand the provisions of the Bill that apply to state Medicaid programs. Recognize how the Bill will impact state Medicaid programs and DME suppliers. Learn the steps DME suppliers can take to prepare for cuts in Medicaid spending.Show MoreClick the title to see all details
